AbbVie, Inc. holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 22,227 | $4,657,001 | 0.05% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 22,227 | $4,125,776 | 0.05% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 8, 2025 |
| Sept. 30, 2025 | 18,122 | $4,195,968 | 0.05% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 6, 2025 |
| Dec. 31, 2025 | 11,144 | $2,546,293 | 0.04% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 11,144 | $2,423,709 | 0.05% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 5, 2026 |
| June 30, 2026 | 11,064 | $2,784,145 | 0.07% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 7, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.